Cost-Effectiveness Of Midostaurin In The Treatment Of Acute Myeloid Leukemia With The FLT3 Mutation In Spain

PURPOSE: The addition of midostaurin to standard chemotherapy (cytarabine and daunorubicin) has shown significant improvements in the survival of patients with acute myeloid leukemia with the FLT3 mutation (FLT3-AML). The objective of this study was to determine whether this intervention would be co...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clinicoecon Outcomes Res
Main Authors: Arenaza, Ainhoa, Diez, Raúl, Esteve, Jordi, Di Nicolantonio, Roberta, Gostkorzewicz, Joana, Martínez, Carlos, Martínez Llinàs, Diana, Martinez-Lopez, Joaquin, Montesinos, Pau, Moure-Fernández, Aída, Sierra, Jorge, Vinent, Joan Lluís
Formato: Artigo
Idioma:Inglês
Publicado em: Dove 2019
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6859089/
https://ncbi.nlm.nih.gov/pubmed/32009807
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S222879
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados